Table 2 Frequency of marker expression in ovarian and lower gastrointestinal tumors
Lower gastrointestinal | Ovarian | ||||||
|---|---|---|---|---|---|---|---|
Subtype | Total | CRC | Appendiceal | Total | MBOT | MC | |
N | 230 | 123 | 107 | 155 | 50 | 105 | |
CK7 | Absent (n, %) | 186 | 110 | 76 | 4 | 3 | 1 |
80.9 | 89.4 | 71.0 | 2.6 | 6.0 | 1.0 | ||
Focal (n, %) | 26 | 8 | 18 | 10 | 6 | 4 | |
11.3 | 6.5 | 16.8 | 6.5 | 12.0 | 3.8 | ||
Diffuse (n, %) | 18 | 5 | 13 | 141 | 41 | 100 | |
7.8 | 4.1 | 12.1 | 91.0 | 82.0 | 95.2 | ||
Present (%) | 19.1 | 10.6 | 29.0 | 97.4 | 94.0 | 99.0 | |
CK20 | Absent (n, %) | 30 | 12 | 18 | 28 | 11 | 17 |
13.0 | 9.8 | 16.8 | 18.1 | 22.0 | 16.2 | ||
Focal (n, %) | 38 | 26 | 12 | 60 | 16 | 44 | |
16.5 | 21.1 | 11.2 | 38.7 | 32.0 | 41.9 | ||
Diffuse (n, %) | 162 | 85 | 77 | 67 | 23 | 44 | |
70.4 | 69.1 | 72.0 | 43.2 | 46.0 | 41.9 | ||
Present (%) | 87.0 | 90.2 | 83.2 | 81.9 | 78.0 | 83.8 | |
CDX2 | Absent (n, %) | 4 | 1 | 3 | 47 | 7 | 40 |
1.7 | 0.8 | 2.8 | 30.3 | 14.0 | 38.1 | ||
Focal (n, %) | 18 | 12 | 6 | 60 | 20 | 40 | |
7.8 | 9.8 | 5.6 | 38.7 | 40.0 | 38.1 | ||
Diffuse (n, %) | 208 | 110 | 98 | 48 | 23 | 25 | |
90.4 | 89.4 | 91.6 | 31.0 | 46.0 | 23.8 | ||
Present (%) | 98.3 | 99.2 | 97.2 | 69.7 | 86.0 | 61.9 | |
SATB2 | Absent (n, %) | 23 | 10 | 13 | 135 | 44 | 91 |
10.0 | 8.1 | 12.1 | 87.1 | 88.0 | 86.7 | ||
Focal (n, %) | 23 | 19 | 4 | 11 | 3 | 8 | |
10.0 | 15.4 | 3.7 | 7.1 | 6.0 | 7.6 | ||
Diffuse (n, %) | 184 | 94 | 90 | 9 | 3 | 6 | |
80.0 | 76.4 | 84.1 | 5.8 | 6.0 | 5.7 | ||
Present (%) | 90.0 | 91.9 | 87.9 | 12.9 | 12.0 | 13.3 | |
PAX8 | Absent (n, %) | 224 | 123 | 101 | 85 | 29 | 56 |
97.4 | 100.0 | 94.4 | 54.8 | 58.0 | 53.3 | ||
Focal (n, %) | 0 | 0 | 0 | 52 | 14 | 38 | |
0.0 | 0.0 | 0.0 | 33.5 | 28.0 | 36.2 | ||
Diffuse (n, %) | 6 | 0 | 6 | 18 | 7 | 11 | |
2.6 | 0.0 | 5.6 | 11.6 | 14.0 | 10.5 | ||
Present (%) | 2.6 | 0.0 | 5.6 | 45.2 | 42.0 | 46.7 | |
